|
1
|
Jain M, Rojanaporn D, Chawla B, Sundar G,
Gopal L and Khetan V: Retinoblastoma in Asia. Eye (Lond). 33:87–96.
2019. View Article : Google Scholar
|
|
2
|
Francis JH, Roosipu N, Levin AM, Brodie
SE, Dunkel IJ, Gobin YP and Abramson DH: Current treatment of
bilateral retinoblastoma: The impact of intraarterial and
intravitreous chemotherapy. Neoplasia. 20:757–763. 2018. View Article : Google Scholar
|
|
3
|
Abramson DH, Shields CL, Munier FL and
Chantada GL: Treatment of retinoblastoma in 2015: Agreement and
disagreement. JAMA Ophthalmol. 133:1341–1347. 2015. View Article : Google Scholar
|
|
4
|
Xu L, Li W, Shi Q, Wang M, Li H, Yang X
and Zhang J: MicroRNA-936 inhibits the malignant phenotype of
retinoblastoma by directly targeting HDAC9 and deactivating the
PI3K/AKT pathway. Oncol Rep. 43:635–645. 2020.
|
|
5
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View
Article : Google Scholar
|
|
6
|
Kitamura T, Qian BZ and Pollard JW: Immune
cell promotion of metastasis. Nat Rev Immunol. 15:73–86. 2015.
View Article : Google Scholar
|
|
7
|
Sica A and Mantovani A: Macrophage
plasticity and polarization: In vivo veritas. J Clin Invest.
122:787–795. 2012. View
Article : Google Scholar
|
|
8
|
Kim J and Bae JS: Tumor-associated
macrophages and neutrophils in tumor microenvironment. Mediators
Inflamm. 2016:60581472016. View Article : Google Scholar
|
|
9
|
Saunderson SC, Dunn AC, Crocker PR and
McLellan AD: CD169 mediates the capture of exosomes in spleen and
lymph node. Blood. 123:208–216. 2014. View Article : Google Scholar
|
|
10
|
DeNardo DG, Brennan DJ, Rexhepaj E,
Ruffell B, Shiao SL, Madden SF, Gallagher WM, Wadhwani N, Keil SD,
Junaid SA, et al: Leukocyte complexity predicts breast cancer
survival and functionally regulates response to chemotherapy.
Cancer Discov. 1:54–67. 2011. View Article : Google Scholar
|
|
11
|
Théry C, Zitvogel L and Amigorena S:
Exosomes: Composition, biogenesis and function. Nat Rev Immunol.
2:569–579. 2002. View
Article : Google Scholar
|
|
12
|
Mathieu M, Martin-Jaular L, Lavieu G and
Théry C: Specificities of secretion and uptake of exosomes and
other extracellular vesicles for cell-to-cell communication. Nat
Cell Biol. 21:9–17. 2019. View Article : Google Scholar
|
|
13
|
Peinado H, Alečković M, Lavotshkin S,
Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M,
Williams C, García-Santos G, Ghajar CM, et al: Melanoma exosomes
educate bone marrow progenitor cells toward a pro-metastatic
phenotype through MET. Nat Med. 18:883–891. 2012. View Article : Google Scholar
|
|
14
|
Maji S, Chaudhary P, Akopova I, Nguyen PM,
Hare RJ, Gryczynski I and Vishwanatha JK: Exosomal annexin II
promotes angiogenesis and breast cancer metastasis. Mol Cancer Res.
15:93–105. 2017. View Article : Google Scholar
|
|
15
|
Messenger SW, Woo SS, Sun Z and Martin
TFJ: A Ca2+-stimulated exosome release pathway in cancer cells is
regulated by Munc13-4. J Cell Biol. 217:2877–2890. 2018. View Article : Google Scholar
|
|
16
|
Haga H, Yan IK, Takahashi K, Wood J,
Zubair A and Patel T: Tumour cell-derived extracellular vesicles
interact with mesenchymal stem cells to modulate the
microenvironment and enhance cholangiocarcinoma growth. J Extracell
Vesicles. 4:249002015. View Article : Google Scholar
|
|
17
|
Boyiadzis M and Whiteside TL: The emerging
roles of tumor-derived exosomes in hematological malignancies.
Leukemia. 31:1259–1268. 2017. View Article : Google Scholar
|
|
18
|
Feng Q, Zhang C, Lum D, Druso JE, Blank B,
Wilson KF, Welm A, Antonyak MA and Cerione RA: A class of
extracellular vesicles from breast cancer cells activates VEGF
receptors and tumour angiogenesis. Nat Commun. 8:144502017.
View Article : Google Scholar
|
|
19
|
Klingeborn M, Dismuke WM, Rickman CB and
Stamer WD: Roles of exosomes in the normal and diseased eye. Prog
Retin Eye Res. 59:158–177. 2017. View Article : Google Scholar
|
|
20
|
Soleimani M and Nadri S: A protocol for
isolation and culture of mesenchymal stem cells from mouse bone
marrow. Nat Protoc. 4:102–106. 2009. View Article : Google Scholar
|
|
21
|
Théry C, Clayton A, Amigorena S and Raposo
G: Isolation and characterization of exosomes from cell culture
supernatants and biological fluids. Curr Protoc Cell Biol. Chapter
3: Unit 3.22. 2006. View Article : Google Scholar
|
|
22
|
Tian Y, Ma L, Gong M, Su G, Zhu S, Zhang
W, Wang S, Li Z, Chen C, Li L, et al: Protein Profiling and Sizing
of Extracellular Vesicles from Colorectal Cancer Patients via Flow
Cytometry. ACS Nano. 12:671–680. 2018. View Article : Google Scholar
|
|
23
|
Friedrich R, Block S, Alizadehheidari M,
Heider S, Fritzsche J, Esbjörner EK, Westerlund F and Bally M: A
nano flow cytometer for single lipid vesicle analysis. Lab on a
Chip. 17:830–841. 2017. View Article : Google Scholar
|
|
24
|
Hoshino A, Costa-Silva B, Shen T,
Rodrigues G, Hashimoto A, Mark MT, Molina H, Kohsaka S, Giannatale
AD, Ceder S, et al: Tumour exosome integrins determine organotropic
metastasis. Nature. 527:329–335. 2015. View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Paschos GK, Ibrahim S, Song WL, Kunieda T,
Grant G, Reyes TM, Bradfield CA, Vaughan CH, Eiden M, Masoodi M, et
al: Obesity in mice with adipocyte-specific deletion of clock
component Arntl. Nat Med. 18:1768–1777. 2012. View Article : Google Scholar
|
|
27
|
Connor KM, Krah NM, Dennison RJ, Aderman
CM, Chen J, Guerin KI, Sapieha P, Stahl A, Willett KL and Smith LE:
Quantification of oxygen-induced retinopathy in the mouse: A model
of vessel loss, vessel regrowth and pathological angiogenesis. Nat
Protoc. 4:1565–1573. 2009. View Article : Google Scholar
|
|
28
|
Balkwill F: The significance of cancer
cell expression of the chemokine receptor CXCR4. Seminars in cancer
biology. Semin Cancer Biol. 14:171–179. 2004. View Article : Google Scholar
|
|
29
|
Cao Y, Guangqi E, Wang E, Pal K, Dutta SK,
Bar-Sagi D and Mukhopadhyay D: VEGF exerts an
angiogenesis-independent function in cancer cells to promote their
malignant progression. Cancer Res. 72:3912–3918. 2012. View Article : Google Scholar
|
|
30
|
Ortega J, Li JY, Lee S, Tong D, Gu L and
Li GM: Phosphorylation of PCNA by EGFR inhibits mismatch repair and
promotes misincorporation during DNA synthesis. Proc Natl Acad Sci
USA. 112:5667–5672. 2015. View Article : Google Scholar
|
|
31
|
Zhao N, Tsuda H, Murofushi T, Imai K,
Ochiai K, Yang P and Suzuki N: Chaetocin inhibits RANKL-induced
osteoclast differentiation through reduction of Blimp1 in Raw264.7
cells. Life Sci. 143:1–7. 2015. View Article : Google Scholar
|
|
32
|
Ara T, Song L, Shimada H, Keshelava N,
Russell HV, Metelitsa LS, Groshen SG, Seeger RC and DeClerck YA:
Interleukin-6 in the bone marrow microenvironment promotes the
growth and survival of neuroblastoma cells. Cancer Res. 69:329–337.
2009. View Article : Google Scholar
|
|
33
|
Tang Z, Li D, Hou S and Zhu X: The cancer
exosomes: Clinical implications, applications and challenges. Int J
Cancer. 146:2946–2959. 2020. View Article : Google Scholar
|
|
34
|
Yerushalmi R, Woods R, Ravdin PM, Hayes MM
and Gelmon KA: Ki67 in breast cancer: Prognostic and predictive
potential. Lancet Oncol. 11:174–183. 2010. View Article : Google Scholar
|
|
35
|
Pastushenko I, Brisebarre A, Sifrim A,
Fioramonti M, Revenco T, Boumahdi S, Keymeulen AV, Brown D, Moers
V, Lemaire S, et al: Identification of the tumour transition states
occurring during EMT. Nature. 556:463–468. 2018. View Article : Google Scholar
|
|
36
|
Chen Z, Pan X, Georgakilas AG, Chen P, Hu
H, Yang Y, Tian S, Xia L, Zhang J, Cai X, et al:
Tetramethylpyrazine (TMP) protects cerebral neurocytes and inhibits
glioma by down regulating chemokine receptor CXCR4 expression.
Cancer Lett. 336:281–289. 2013. View Article : Google Scholar
|
|
37
|
Chen Q, Zhang JJ, Ge WL, Chen L, Yuan H,
Meng LD, Huang XM, Shen P, Miao Y and Jiang KR: YY1 inhibits the
migration and invasion of pancreatic ductal adenocarcinoma by
downregulating the FER/STAT3/MMP2 signaling pathway. Cancer Lett.
463:37–49. 2019. View Article : Google Scholar
|
|
38
|
Takase N, Koma Y, Urakawa N, Nishio M,
Arai N, Akiyama H, Shigeoka M, Kakeji Y and Yokozaki H: NCAM-and
FGF-2-mediated FGFR1 signaling in the tumor microenvironment of
esophageal cancer regulates the survival and migration of
tumor-associated macrophages and cancer cells. Cancer Lett.
380:47–58. 2016. View Article : Google Scholar
|
|
39
|
Esbona K, Yi Y, Saha S, Yu M, Doorn RV,
Conklin MW, Graham DS, Wisinski KB, Ponik SM, Eliceiri KW, et al:
The presence of cyclooxygenase 2, tumor-associated macrophages, and
collagen alignment as prognostic markers for invasive breast
carcinoma patients. Am J Pathol. 188:559–573. 2018. View Article : Google Scholar
|
|
40
|
Shultz LD, Lyons BL, Burzenski LM, Gott B,
Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, et al:
Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R
gamma null mice engrafted with mobilized human hemopoietic stem
cells. J Immunol. 174:6477–6489. 2005. View Article : Google Scholar
|
|
41
|
Shultz LD, Goodwin N, Ishikawa F, Hosur V,
Lyons BL and Greiner DL: Human cancer growth and therapy in
NOD/SCID/IL2Rγnull (NSG) mice. Cold Spring Harbor Protocols.
2014:6942014. View Article : Google Scholar
|
|
42
|
Bartal I, Melamed R, Greenfeld K, Atzil S,
Glasner A, Domankevich V, Naor R, Beilin B, Yardeni IZ and
Ben-Eliyahu S: Immune perturbations in patients along the
perioperative period: Alterations in cell surface markers and
leukocyte subtypes before and after surgery. Brain Behav Immun.
24:376–86. 2010. View Article : Google Scholar
|
|
43
|
Arase H, Saito T, Phillips JH and Lanier
LL: Cutting edge: The mouse NK cell-associated antigen recognized
by DX5 moncoclonal antibody is CD49b (α2 integrin, very late
antigen-2). J Immunol. 167:1141–1144. 2001. View Article : Google Scholar
|
|
44
|
Chen P, Yu N, Zhang Z, Zhang P, Yang Y, Wu
N, Xu L, Zhang J, Ge J, Yu K, et al: Thrombospondin-1 might be a
therapeutic target to suppress RB cells by regulating the DNA
double-strand breaks repair. Oncotarget. 7:6105–6120. 2016.
View Article : Google Scholar
|
|
45
|
Hirschberger S, Hinske LC and Kreth S:
MiRNAs: Dynamic regulators of immune cell functions in inflammation
and cancer. Cancer Lett. 431:11–21. 2018. View Article : Google Scholar
|
|
46
|
Casadei L, Calore F, Creighton CJ,
Guescini M, Batte K, Iwenofu OH, Zewdu A, Braggio DA, Bill KL,
Fadda P, et al: Exosome-derived miR-25-3p and miR-92a-3p stimulate
liposarcoma progression. Cancer Res. 77:3846–3856. 2017. View Article : Google Scholar
|
|
47
|
Xu Z, Zhao L, Zhu LY, He M, Zheng L and Wu
Y: MicroRNA-17, 20a regulates the proangiogenic function of
tumor-associated macrophages via targeting hypoxia-inducible factor
2α. PLoS One. 8:e778902013. View Article : Google Scholar
|
|
48
|
Kim DI, Kim E, Kim YA, Cho SW, Lim JA and
Park YJ: Macrophage densities correlated with CXC chemokine
receptor 4 expression and related with poor survival in anaplastic
thyroid cancer. Endocrinol Metab (Seoul). 31:469–475. 2016.
View Article : Google Scholar
|
|
49
|
Xiao M, Zhang J and Chen W and Chen W:
M1-like tumor-associated macrophages activated by
exosome-transferred THBS1 promote malignant migration in oral
squamous cell carcinoma. J Exp Clin Cancer Res. 37:1432018.
View Article : Google Scholar
|
|
50
|
Bonauer A, Carmona G, Iwasaki M, Mione M,
Koyanagi M, Fischer A, Burchefield J, Fox H, Doebele C, Ohtani K,
et al: MicroRNA-92a controls angiogenesis and functional recovery
of ischemic tissues in mice. Science. 324:1710–1713. 2009.
View Article : Google Scholar
|
|
51
|
Mathiyalagan P, Liang Y, Kim D, Misener S,
Thorne T, Kamide CE, Klyachko E, Losordo DW, Hajjar RJ and Sahoo S:
Angiogenic mechanisms of human CD34+ stem cell exosomes
in the repair of ischemic hindlimb. Circ Res. 120:1466–1476. 2017.
View Article : Google Scholar
|
|
52
|
Tkach M and Théry C: Communication by
extracellular vesicles: Where we are and where we need to go. Cell.
164:1226–1232. 2016. View Article : Google Scholar
|
|
53
|
Huang X, Yuan T, Liang M, Du M, Xia S,
Dittmar R, Wang D, See W, Costello BA, Quevedo F, et al: Exosomal
miR-1290 and miR-375 as prognostic markers in castration-resistant
prostate cancer. Eur Urol. 67:33–41. 2015. View Article : Google Scholar
|
|
54
|
Tsuchida R, Osawa T, Wang F, Nishii R, Das
B, Tsuchida S, Muramatsu M, Takahashi T, Inoue T, Wada Y, et al:
BMP4/Thrombospondin-1 loop paracrinically inhibits tumor
angiogenesis and suppresses the growth of solid tumors. Oncogene.
33:3803–3811. 2014. View Article : Google Scholar
|
|
55
|
Ramchandani D and Mittal V: Thrombospondin
in tumor microenvironment. Adv Exp Med Biol. 1272:133–147. 2020.
View Article : Google Scholar
|
|
56
|
Firlej V, Mathieu JR, Gilbert C, Lemonnier
L, Nakhlé J, Gallou-Kabani C, Guarmit B, Morin A, Prevarskaya N,
Delongchamps NB, et al: Thrombospondin-1 triggers cell migration
and development of advanced prostate tumors. Cancer Res.
71:7649–7658. 2011. View Article : Google Scholar
|
|
57
|
Horiguchi H, Yamagata S, Rong Qian Z,
Kagawa S and Sakashita N: Thrombospondin-1 is highly expressed in
desmoplastic components of invasive ductal carcinoma of the breast
and associated with lymph node metastasis. J Med Invest. 60:91–96.
2013. View Article : Google Scholar
|
|
58
|
Borsotti P, Ghilardi C, Ostano P, Silini
A, Dossi R, Pinessi D, Foglieni C, Scatolini M, Lacal PM, Ferrari
R, et al: Thrombospondin-1 is part of a Slug-independent motility
and metastatic program in cutaneous melanoma, in association with
VEGFR-1 and FGF-2. Pigment Cell Melanoma Res. 28:73–81. 2015.
View Article : Google Scholar
|
|
59
|
Byrne GJ, Hayden KE, McDowell G, Lang H,
Kirwan CC, Tetlow L, Kumar S and Bundred NJ: Angiogenic
characteristics of circulating and tumoural thrombospondin-1 in
breast cancer. Int J Oncol. 31:1127–1132. 2007.
|
